- Home
- Publications
- Publication Search
- Publication Details
Title
Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures
Authors
Keywords
Calcium-sensing receptor, Calcimimetic, Calcilytic, Cinacalcet, Hyperparathyroidism, Osteoporosis, Autosomal dominant hypocalcemia
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 98, Issue 4, Pages 341-358
Publisher
Springer Nature
Online
2015-08-29
DOI
10.1007/s00223-015-0052-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation
- (2016) Myles Wolf et al. TRANSPLANTATION
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients
- (2015) Gregory Bell et al. CURRENT MEDICAL RESEARCH AND OPINION
- Parathyroid hormone: anabolic and catabolic actions on the skeleton
- (2015) Barbara C Silva et al. CURRENT OPINION IN PHARMACOLOGY
- Population pharmacokinetics analysis of AMG 416, an allosteric activator of the calcium-sensing receptor, in subjects with secondary hyperparathyroidism receiving hemodialysis
- (2015) Ping Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
- (2015) Geert J. Behets et al. KIDNEY INTERNATIONAL
- The calcium-sensing receptor in bone—mechanistic and therapeutic insights
- (2015) David Goltzman et al. Nature Reviews Endocrinology
- Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma
- (2015) Polina L. Yarova et al. Science Translational Medicine
- A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism
- (2014) P. Evenepoel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women
- (2014) Markus R. John et al. BONE
- A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study of the Calcium-Sensing Receptor Antagonist MK-5442 in the Treatment of Postmenopausal Women With Osteoporosis
- (2014) Johan Halse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial
- (2014) S. M. Moe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia
- (2014) Saskia Letz et al. PLoS One
- Comparison of AMG 416 and cinacalcet in rodent models of uremia
- (2014) Sarah Walter et al. BMC Nephrology
- Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism
- (2013) Fadil M. Hannan et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders
- (2013) Edward F. Nemeth et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women
- (2013) Stephen Caltabiano et al. BONE
- Impact of Clinically Relevant Mutations on the Pharmacoregulation and Signaling Bias of the Calcium-Sensing Receptor by Positive and Negative Allosteric Modulators
- (2013) Katie Leach et al. ENDOCRINOLOGY
- Calcium Regulates FGF-23 Expression in Bone
- (2013) Valentin David et al. ENDOCRINOLOGY
- Loss-of-Function and Gain-of-Function Mutations of Calcium-Sensing Receptor: Functional Analysis and the Effect of Allosteric Modulators NPS R-568 and NPS 2143
- (2013) Akie Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients
- (2013) Kevin J. Martin et al. KIDNEY INTERNATIONAL
- Germline Mutations Affecting Gα11 in Hypoparathyroidism
- (2013) Michael Mannstadt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Affecting G-Protein Subunit α11 in Hypercalcemia and Hypocalcemia
- (2013) M. Andrew Nesbit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary arterial hypertension
- (2013) David Montani et al. Orphanet Journal of Rare Diseases
- Calcimimetics and outcomes in CKD
- (2013) Tilman B. Drüeke Kidney International Supplements
- Pharmacodynamic Responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats
- (2012) John E. Fisher et al. BONE
- Enhanced Ca 2+ -Sensing Receptor Function in Idiopathic Pulmonary Arterial Hypertension
- (2012) Aya Yamamura et al. CIRCULATION RESEARCH
- Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914
- (2012) So Young Park et al. CLINICAL ENDOCRINOLOGY
- Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites
- (2012) F. M. Hannan et al. HUMAN MOLECULAR GENETICS
- PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor
- (2012) Alexandre Loupy et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans
- (2011) Markus R. John et al. BONE
- Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: Results of a randomized, double-blinded, placebo-controlled Phase II clinical trial
- (2011) Lorraine A. Fitzpatrick et al. BONE
- An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
- (2011) H.H. Malluche et al. CLINICAL NEPHROLOGY
- JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats
- (2011) Shuichi Kimura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis
- (2011) Leo Widler Future Medicinal Chemistry
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women
- (2011) Lorraine A Fitzpatrick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral Density
- (2011) Lorraine A. Fitzpatrick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Relationship of Airway Hyperresponsiveness and Airway Inflammation
- (2010) William W. Busse CHEST
- Novel Activating Mutations of the Calcium-Sensing Receptor: The Calcilytic NPS-2143 Mitigates Excessive Signal Transduction of Mutant Receptors
- (2010) Saskia Letz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation
- (2009) Sanjay Kumar et al. BONE
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study
- (2009) Munro Peacock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Cinacalcet Hydrochloride on Bone Histology in Patients with Secondary Hyperparathyroidism
- (2009) Aiji Yajima et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Effect of Cinacalcet on Hypercalcemia and Bone Mineral Density in Renal Transplanted Patients With Secondary Hyperparathyroidism
- (2009) Carlos Bergua et al. TRANSPLANTATION
- Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion
- (2008) Hillel Galitzer et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started